Flagship Pioneering Merges Three Firms to Launch New Biotech Start-up Etcelera
Flagship Pioneering merged Cellarity, Empress Therapeutics, and Etiome to form Etcelera, a biotech firm developing drug candidates for blood and immunological diseases using computational biology. One
cen · 2026-10-29 00:00 UTC